Pathology- Dementia with Lewy Bodies (DLB)

I. Definition & Epidemiology

• Definition: DLB is a neurodegenerative disease. Clinically, it presents as dementia. Histopathologically (microscopically), it's characterized by the presence of Lewy bodies in brain neurons (both cortical and subcortical).
• Epidemiology:
  • Second most common cause of dementia.
  • Prevalence: ~5% in individuals >85 years old.
  • Slightly more prevalent in men.

II. Etiology & Pathogenesis

• Etiology (Cause): Unknown.
• Pathogenesis (Mechanism): The accumulation of Lewy bodies within neurons is believed to cause neuronal damage and subsequent cell loss, leading to the clinical manifestations of DLB.

III. Clinical Presentation & Differentiation from Alzheimer's Disease (AD)

• Presentation: Progressively worsening dementia, similar to Alzheimer's Disease (AD).
• Key Distinguishing Features from AD: This is crucial for diagnosis! DLB presents with:
  • Fluctuating cognition: Mental clarity varies significantly throughout the day or week.
  • Recurrent visual hallucinations: Patients experience vivid, often repetitive, visual hallucinations.
  • Parkinsonism: Features of Parkinson's disease, such as tremors, rigidity, and slow movement, may be present.

IV. Macroscopic & Microscopic Findings (Pathology)

• Macroscopy (Gross Examination):
  • Cerebral atrophy (brain shrinkage), particularly in the temporal and parietal lobes.
  • Loss of pigment in the substantia nigra (a brain region crucial for movement control).
• Histopathology (Microscopic Examination):
  • Lewy bodies: Intracytoplasmic (within the cell's cytoplasm) inclusions composed of α-synuclein, ubiquitin, and parkin. These are the hallmark of DLB.
  • AD-like changes: Amyloid plaques and neurofibrillary tangles (characteristic of Alzheimer's) are often present but areas typically severely affected in AD (like the hippocampus) are usually spared in DLB. This is a critical differentiator.

V. Prognosis

• Highly variable, but the average survival after diagnosis is 5-7 years.

VI. Summary Table for Comparison with Alzheimer's Disease